NCT02473809 The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function Status COMPLETED Phase PHASE4
NCT02472717 Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study Status WITHDRAWN Phase PHASE2
NCT02470039 Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy Status COMPLETED Phase PHASE2
NCT02461589 Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT02453711 Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT02453685 A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients Status COMPLETED Phase PHASE4
NCT02443155 A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function Status COMPLETED Phase PHASE2
NCT02420262 A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT02408705 Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects Status COMPLETED Phase PHASE2
NCT02403284 The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans Status COMPLETED Phase PHASE4
NCT02392117 Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT02382939 A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency Status COMPLETED Phase PHASE3
NCT02371239 SIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabetes Mellitus Type 2 Status COMPLETED Phase NA
NCT02321878 Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®) Status COMPLETED Phase N/A
NCT02306681 A Survey on Low Blod Sugar Among Insulin-treated Patients With Diabetes Status COMPLETED Phase N/A
NCT02305381 Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT02304627 Effect of Food on the Pharmacokinetics of NNC0123-0000-0338 in a Tablet Formulation in Healthy Subjects Status COMPLETED Phase PHASE1